Delivery Order SPE2DB20D1110-SPE2DB25FK27D
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $10,328.41 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025 with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET, a prescription medication, to the Defense Logistics Agency (DLA). The $12,278.75 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 11, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,923.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. This award is associated with Amerisourcebergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $15,504.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 4, 2025 with an ultimate completion date of April 7, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a ceiling value of $7,053.98 and an ultimate completion date of February 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $15,693.52 and is a firm fixed price delivery order awarded on May 23, 2024, with a completion date of May 24, 2024. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,772.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024 with a completion date of December 31, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. In addition to this specific award, AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $6,361.06 and a completion date of April 24, 2024. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $91,954.04 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025 with a completion date of May 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award, with ID SPE2DB22D3301|SPE2DB25FY2UF, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $4,517.87 firm fixed-price contract was awarded on April 7, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of April 8, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...